jrnl7528

Publication Venue For

  • Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial.  59:201-207. 2019
  • Alterations in mitochondrial fission, fusion, and mitophagic protein expression in the gastrocnemius of mice after a sciatic nerve transection.  58:592-599. 2018
  • Needle electromyography practice patterns in patients taking novel oral anticoagulants: A survey-based study.  58:307-309. 2018
  • Gender and quality of life in myasthenia gravis patients from the myasthenia gravis foundation of America registry.  58:90-98. 2018
  • Genetic modifiers of Duchenne and facioscapulohumeral muscular dystrophies.  57:6-15. 2018
  • Quantification and characterization of grouped type I myofibers in human aging.  57:E52-E59. 2018
  • Subacute demyelinating polyradiculoneuropathy complicating Epstein–Barr virus infection in GATA2 haploinsufficiency.  57:150-156. 2018
  • International clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15r.  54:1015-1022. 2016
  • Ocular LEMS or MLOS.  54:981-982. 2016
  • Comparisons of ultrasound-estimated intramuscular fat with fitness and health indicators.  54:743-749. 2016
  • Clinical spectrum of valosin containing protein (VCP)-opathy.  54:94-99. 2016
  • Acute myofascitis as a manifestation of chronic graft-versus-host disease.  53:327-329. 2016
  • Measurement of intramuscular fat by muscle echo intensity.  52:963-971. 2015
  • Changes in α7β1 integrin signaling after eccentric exercise in heat-shocked rat soleus.  51:562-568. 2015
  • Mechanosensitivity may be enhanced in skeletal muscles of spinal cord-injured versus able-bodied men.  50:599-601. 2014
  • Mechanosensitivity may be enhanced in skeletal muscles of spinal cord-injured versus able-bodied men 2014
  • Does change in acetylcholine receptor antibody level correlate with clinical change in myasthenia gravis?.  49:483-486. 2014
  • The role of chemokines in guillain-barré syndrome.  48:320-330. 2013
  • A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis.  48:76-84. 2013
  • Reply.  47:145-146. 2013
  • Psychometric evaluation of the myasthenia gravis composite using rasch analysis.  45:820-825. 2012
  • Recommendations for myasthenia gravis clinical trials.  45:909-917. 2012
  • Subacute brachial diplegia associated with west nile virus myelitis.  45:900-904. 2012
  • Re: Practice parameters in myasthenia gravis.  44:1001. 2011
  • Isolation and transcriptome analysis of adult zebrafish cells enriched for skeletal muscle progenitors.  43:741-750. 2011
  • Practice parameters and focusing research: Plasma exchange for myasthenia gravis.  43:625-626. 2011
  • Intraoperative on-nerve nerve conduction study and conversion factor in the sural nerve.  42:373-378. 2010
  • Dorsal caudal tail and sciatic motor nerve conduction studies in adult mice: Technical aspects and normative data.  41:850-856. 2010
  • 3,4-Diaminopyridine is more effective than placebo in a randomized, double-blind, cross-over drug study in LEMS.  40:795-800. 2009
  • Racial differences in myasthenia gravis in Alabama.  39:328-332. 2009
  • Construction of an efficient evaluative instrument for myasthenia gravis: The MG composite.  38:1553-1562. 2008
  • Statins may aggravate myasthenia gravis.  38:1101-1107. 2008
  • Less is more, or almost as much: A 15-item quality-of-life instrument for myasthenia gravis.  38:957-963. 2008
  • Electrophysiological differences in seropositive and seronegative Lambert-Eaton myasthenic syndrome.  35:178-183. 2007
  • Exercise-induced cramp, myoglobinuria, and tubular aggregates in phosphoglycerate mutase deficiency.  34:572-576. 2006
  • Electrodiagnostic criteria for carpal tunnel syndrome in axonal polyneuropathy.  33:747-752. 2006
  • Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis.  33:500-504. 2006
  • Adult polyglucosan body disease: A case report of a manifesting heterozygote.  32:675-681. 2005
  • Electrophysiological diagnostic criteria of Lambert-Eaton myasthenic syndrome.  32:515-520. 2005
  • Myokymia, neuromyotonia, dermatomyositis, and voltage-gated K+ channel antibodies.  27:757-760. 2003
  • Relation between in vivo and in vitro measurements of skeletal muscle oxidative metabolism.  24:1665-1676. 2001
  • Muscle metabolic economy is inversely related to exercise intensity and type II myofiber distribution.  24:654-661. 2001
  • Distal sensory nerve conduction of the superficial peroneal nerve: new method and its clinical application..  24:689-694. 2001
  • Distal sensory nerve conduction of the superficial peroneal nerve: New method and its clinical application.  24:689-694. 2001
  • Iatrogenic superior gluteal mononeuropathy.  21:1794-1796. 1998
  • Iatrogenic superior gluteal mononeuropathy..  21:1794-1796. 1998
  • Stiff-persons' syndrome associated with thymoma and subsequent myasthenia gravis.  20:493-498. 1997
  • Primary respiratory failure as the presenting symptom in Lambert–Eaton myasthenic syndrome.  16:712-715. 1993
  • A benign form of reducing body myopathy.  6:278-282. 1983
  • Multiple sclerosis and hypertrophic demyelinating peripheral neuropathy.  6:312-316. 1983
  • Preparation of cell‐free extracellular matrix from human peripheral nerve.  5:335-344. 1982